BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35112216)

  • 1. 3D pseudo-continuous arterial spin labeling-MRI (3D PCASL-MRI) in the differential diagnosis between glioblastomas and primary central nervous system lymphomas.
    Batalov AI; Afandiev RM; Zakharova NE; Pogosbekyan EL; Shulgina AA; Kobyakov GL; Potapov AA; Pronin IN
    Neuroradiology; 2022 Aug; 64(8):1539-1545. PubMed ID: 35112216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of 3D-pCASL MRI in the Differential Diagnosis of Glioblastoma and Brain Metastases.
    Solozhentseva K; Batalov A; Zakharova N; Goryaynov S; Pogosbekyan E; Pronin I
    Front Oncol; 2022; 12():874924. PubMed ID: 35558515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling.
    Yu X; Hong W; Ye M; Lai M; Shi C; Li L; Ye K; Xu J; Ai R; Shan C; Cai L; Luo L
    Eur Radiol; 2023 Aug; 33(8):5357-5367. PubMed ID: 37171492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of Primary Central Nervous System Lymphoma From Glioblastoma: Quantitative Analysis Using Arterial Spin Labeling and Diffusion Tensor Imaging.
    Abdel Razek AAK; El-Serougy L; Abdelsalam M; Gaballa G; Talaat M
    World Neurosurg; 2019 Mar; 123():e303-e309. PubMed ID: 30502475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Skull Base Lesions Using Pseudo-Continuous Arterial Spin Labeling.
    Geerts B; Leclercq D; Tezenas du Montcel S; Law-Ye B; Gerber S; Bernardeschi D; Galanaud D; Dormont D; Pyatigorskaya N
    Clin Neuroradiol; 2019 Mar; 29(1):75-86. PubMed ID: 28894884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of arterial spin labelling MRI for discriminating atypical high-grade glioma from primary central nervous system lymphoma.
    Di N; Cheng W; Chen H; Zhai F; Liu Y; Mu X; Chu Z; Lu N; Liu X; Wang B
    Clin Radiol; 2019 Feb; 74(2):165.e1-165.e9. PubMed ID: 30415766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
    Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
    Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of brain perfusion in newborns: pulsed arterial spin labeling (PASL) versus pseudo-continuous arterial spin labeling (pCASL).
    Boudes E; Gilbert G; Leppert IR; Tan X; Pike GB; Saint-Martin C; Wintermark P
    Neuroimage Clin; 2014; 6():126-33. PubMed ID: 25379424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of multimodal magnetic resonance in the differential diagnosis of acquired immune deficiency syndrome related primary central nervous system lymphoma and infection.
    Li J; Xue M; Yan S; Guan C; Xie R; Chen B
    BMC Infect Dis; 2021 Feb; 21(1):165. PubMed ID: 33568094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma.
    Furtner J; Schöpf V; Preusser M; Asenbaum U; Woitek R; Wöhrer A; Hainfellner JA; Wolfsberger S; Prayer D
    Eur J Radiol; 2014 May; 83(5):806-10. PubMed ID: 24613549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
    Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H
    Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI.
    Wong AM; Yan FX; Liu HL
    J Magn Reson Imaging; 2014 Feb; 39(2):427-33. PubMed ID: 23677620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating between Primary Central Nervous System Lymphoma and Glioblastoma: The Diagnostic Value of Combining
    Hatakeyama J; Ono T; Takahashi M; Oda M; Shimizu H
    Neurol Med Chir (Tokyo); 2021 Jun; 61(6):367-375. PubMed ID: 33967177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma.
    Manning P; Daghighi S; Rajaratnam MK; Parthiban S; Bahrami N; Dale AM; Bolar D; Piccioni DE; McDonald CR; Farid N
    J Neurooncol; 2020 May; 147(3):681-690. PubMed ID: 32239431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.
    Qu Y; Kong D; Wen H; Ou X; Rui Q; Wang X; Lin DD; Qin Q; Wen Z
    Eur Radiol; 2022 May; 32(5):2976-2987. PubMed ID: 35066634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial Spin Labeling Perfusion in Determining the IDH1 Status and Ki-67 Index in Brain Gliomas.
    Batalov AI; Zakharova NE; Chekhonin IV; Pogosbekyan EL; Sudarikova AV; Goryainov SA; Shulgina AA; Belyaev AY; Usachev DY; Pronin IN
    Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor blood flow from arterial spin labeling perfusion MRI: a key parameter in distinguishing high-grade gliomas from primary cerebral lymphomas, and in predicting genetic biomarkers in high-grade gliomas.
    Yoo RE; Choi SH; Cho HR; Kim TM; Lee SH; Park CK; Park SH; Kim IH; Yun TJ; Kim JH; Sohn CH; Han MH; Chang KH
    J Magn Reson Imaging; 2013 Oct; 38(4):852-60. PubMed ID: 23390061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
    You SH; Yun TJ; Choi HJ; Yoo RE; Kang KM; Choi SH; Kim JH; Sohn CH
    Eur Radiol; 2018 Sep; 28(9):3801-3810. PubMed ID: 29619520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cerebral blood flow using multi-phase pseudo continuous arterial spin labeling at 3-tesla.
    Sugimori H; Fujima N; Suzuki Y; Hamaguchi H; Sakata M; Kudo K
    Magn Reson Imaging; 2015 Dec; 33(10):1338-1344. PubMed ID: 26260545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ¹⁸F-fluorodeoxyglucose positron emission tomography.
    Yamashita K; Yoshiura T; Hiwatashi A; Togao O; Yoshimoto K; Suzuki SO; Abe K; Kikuchi K; Maruoka Y; Mizoguchi M; Iwaki T; Honda H
    Neuroradiology; 2013 Feb; 55(2):135-43. PubMed ID: 22961074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.